MedPath

Multi-institutional study to investigate the current status of urological malignancies in Fukushima

Not Applicable
Conditions
rinary Tract Malignancies
Registration Number
JPRN-UMIN000052613
Lead Sponsor
Fukushima Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
1500
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients with other active malignancies (during treatment or within 3 years after treatment) 2) Patients with other comorbidities that make surgical therapy, drug therapy, or histological examination difficult. (iii) Patients for whom normal follow-up, including imaging tests, is impossible due to other comorbidities or other reasons. (iv) Other patients deemed inappropriate by the principal investigator or subinvestigators.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Progression-free survival for each urinary malignancy
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath